Targeting prostate cancer with PSMA-Vδ2 T cell engagement

Publication

This publication investigates a VHH-based PSMA-Vδ2 bispecific T cell engager for prostate cancer. The work supports the broader rationale for redirecting Vγ9Vδ2 T cells toward tumor-associated antigens.